Cargando…

Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data

The stem characteristics of tumor cells have been proposed in theory very early, and we can use the signature of gene expression to speculate the stemness of tumor cells. However, systematic studies on the stemness of breast cancer as well as breast cancer subtypes, and the relationship between stem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Hong, Zhipeng, Kang, Shaohong, Lv, Xinying, Song, Chuangui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926471/
https://www.ncbi.nlm.nih.gov/pubmed/35310908
http://dx.doi.org/10.1155/2022/5694033
_version_ 1784670243226910720
author Chen, Wei
Hong, Zhipeng
Kang, Shaohong
Lv, Xinying
Song, Chuangui
author_facet Chen, Wei
Hong, Zhipeng
Kang, Shaohong
Lv, Xinying
Song, Chuangui
author_sort Chen, Wei
collection PubMed
description The stem characteristics of tumor cells have been proposed in theory very early, and we can use the signature of gene expression to speculate the stemness of tumor cells. However, systematic studies on the stemness of breast cancer as well as breast cancer subtypes, and the relationship between stemness and metastasis and prognosis, are still lacking. In the present research, using the transcriptome data of patients with breast cancer in the TCGA database, a stemness prediction model was utilized to derive the stemness of the patients' tumors. We compared the stemness values among different subtypes and the differences with metastasis. COX regression was employed to evaluate the correlation between stemness value as well as prognosis. Using the Lasso-penalized Cox regression machine learning model, we obtained the gene signature of the basal subtype that is related to stemness and can also predict the prognosis of the patient. Patients can be stratified into two groups of high and low stemness, corresponding to good and poor prognosis. Based on further prediction of tumor infiltration by CIBERSORT and prediction of drug response by a connectivity map, we found that the difference in stemness between these two groups is associated with the activation of tumor-killing immune cells and drug response. Our findings can promote the understanding and research of subtypes of basal breast cancer and provide corresponding molecular markers for clinical detection and therapy.
format Online
Article
Text
id pubmed-8926471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89264712022-03-17 Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data Chen, Wei Hong, Zhipeng Kang, Shaohong Lv, Xinying Song, Chuangui J Oncol Research Article The stem characteristics of tumor cells have been proposed in theory very early, and we can use the signature of gene expression to speculate the stemness of tumor cells. However, systematic studies on the stemness of breast cancer as well as breast cancer subtypes, and the relationship between stemness and metastasis and prognosis, are still lacking. In the present research, using the transcriptome data of patients with breast cancer in the TCGA database, a stemness prediction model was utilized to derive the stemness of the patients' tumors. We compared the stemness values among different subtypes and the differences with metastasis. COX regression was employed to evaluate the correlation between stemness value as well as prognosis. Using the Lasso-penalized Cox regression machine learning model, we obtained the gene signature of the basal subtype that is related to stemness and can also predict the prognosis of the patient. Patients can be stratified into two groups of high and low stemness, corresponding to good and poor prognosis. Based on further prediction of tumor infiltration by CIBERSORT and prediction of drug response by a connectivity map, we found that the difference in stemness between these two groups is associated with the activation of tumor-killing immune cells and drug response. Our findings can promote the understanding and research of subtypes of basal breast cancer and provide corresponding molecular markers for clinical detection and therapy. Hindawi 2022-03-09 /pmc/articles/PMC8926471/ /pubmed/35310908 http://dx.doi.org/10.1155/2022/5694033 Text en Copyright © 2022 Wei Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Wei
Hong, Zhipeng
Kang, Shaohong
Lv, Xinying
Song, Chuangui
Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data
title Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data
title_full Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data
title_fullStr Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data
title_full_unstemmed Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data
title_short Analysis of Stemness and Prognosis of Subtypes in Breast Cancer Using the Transcriptome Sequencing Data
title_sort analysis of stemness and prognosis of subtypes in breast cancer using the transcriptome sequencing data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926471/
https://www.ncbi.nlm.nih.gov/pubmed/35310908
http://dx.doi.org/10.1155/2022/5694033
work_keys_str_mv AT chenwei analysisofstemnessandprognosisofsubtypesinbreastcancerusingthetranscriptomesequencingdata
AT hongzhipeng analysisofstemnessandprognosisofsubtypesinbreastcancerusingthetranscriptomesequencingdata
AT kangshaohong analysisofstemnessandprognosisofsubtypesinbreastcancerusingthetranscriptomesequencingdata
AT lvxinying analysisofstemnessandprognosisofsubtypesinbreastcancerusingthetranscriptomesequencingdata
AT songchuangui analysisofstemnessandprognosisofsubtypesinbreastcancerusingthetranscriptomesequencingdata